DR-01

DB18258InvestigationalProtein Based Therapies

DR-01 is a monoclonal antibody directed against human CD94.

Mechanism: Pharmacologically active on Natural killer cells antigen CD94
Curator reviewed
Also known as: Human anti-CD94 IgG1 monoclonal antibody (non-fucosylated)
Code names: DR-01

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with DR-01, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.